GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (XMAD:GRF) » Definitions » Days Payable

Grifols (XMAD:GRF) Days Payable

: 0.00 (As of Sep. 2023)
View and export this data going back to 2006. Start your Free Trial

Grifols's average Accounts Payable for the three months ended in Sep. 2023 was €0 Mil. Grifols's Cost of Goods Sold for the three months ended in Sep. 2023 was €966 Mil. Hence, Grifols's Days Payable for the three months ended in Sep. 2023 was 0.00.

The historical rank and industry rank for Grifols's Days Payable or its related term are showing as below:

XMAD:GRF' s Days Payable Range Over the Past 10 Years
Min: 64.81   Med: 74.44   Max: 89.42
Current: 89.42

During the past 13 years, Grifols's highest Days Payable was 89.42. The lowest was 64.81. And the median was 74.44.

XMAD:GRF's Days Payable is ranked better than
52.2% of 979 companies
in the Drug Manufacturers industry
Industry Median: 86.61 vs XMAD:GRF: 89.42

Grifols's Days Payable declined from Jun. 2022 (62.89) to Sep. 2023 (0.00). It may suggest that Grifols accelerated paying its suppliers.

Grifols Days Payable Historical Data

The historical data trend for Grifols's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.70 70.02 75.61 64.81 67.41

Grifols Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Days Payable Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.20 59.97 64.01 - 66.04
Competitive Comparison

For the Drug Manufacturers - General subindustry, Grifols's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grifols Days Payable Distribution

For the Drug Manufacturers industry and Healthcare sector, Grifols's Days Payable distribution charts can be found below:

* The bar in red indicates where Grifols's Days Payable falls into.


Grifols Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Grifols's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (731.918 + 781.456) / 2 ) / 4097.406*365
=756.687 / 4097.406*365
=67.41

Grifols's Days Payable for the quarter that ended in Sep. 2023 is calculated as:

Days Payable (Q: Sep. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2023 ) + Accounts Payable (Q: Sep. 2023 )) / count ) / Cost of Goods Sold (Q: Sep. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 965.649*365 / 4
=0 / 965.649*365 / 4
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grifols Days Payable Related Terms

Thank you for viewing the detailed overview of Grifols's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Grifols (XMAD:GRF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (XMAD:GRF) » Definitions » Days Payable
Comparable Companies
XMAD:AEDAS XMAD:NEA XMAD:BKT XMAD:ALB XMAD:NTH XMAD:AZK XMAD:BST XMAD:TRE XMAD:ACX XMAD:ELE LLY JNJ MRK ABBV LSE:AZN XSWX:ROG XSWX:NOVN PFE AMGN XPAR:SAN
Traded in Other Exchanges
GIKLY:USA GIFOF:USA GIFLF:USA GRFS:USA GRFP:Mexico GRFe:UK GRFPe:UK 0RDV:UK 0RDU:UK GRF.P:Spain OZTA:Germany
Address
Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
Website
https://www.grifols.com
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's biopharma business contributed 83% of sales in 2022. Grifols also has smaller segments including diagnostics and biosupplies. Diagnostics is roughly 10% of revenue following the Biotest acquisition.